메뉴 건너뛰기




Volumn 9, Issue 4, 1998, Pages 301-305

Oxaliplatin combined to 5-fluorouracil and folinic acid: An effective therapy in patients with advanced colorectal cancer

Author keywords

5 Fluorouracil; Colorectal cancer; Oxaliplatin

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

EID: 0031747923     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199804000-00002     Document Type: Article
Times cited : (33)

References (20)
  • 1
    • 0028304413 scopus 로고
    • Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines
    • Mamenta EL, Poma EE, Kaufmann WK, et al. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res 1994; 54: 3500-5.
    • (1994) Cancer Res , vol.54 , pp. 3500-3505
    • Mamenta, E.L.1    Poma, E.E.2    Kaufmann, W.K.3
  • 2
    • 0029904811 scopus 로고    scopus 로고
    • The role of DNA mismatch repair in platinum drug resistance
    • Fink D, Nebel S, Aebi S, et al. The role of DNA mismatch repair in platinum drug resistance. Cancer Res 1996; 56: 4881-6.
    • (1996) Cancer Res , vol.56 , pp. 4881-4886
    • Fink, D.1    Nebel, S.2    Aebi, S.3
  • 6
    • 0001704607 scopus 로고    scopus 로고
    • Oxaliplatin (L-OHP) as first-line chemotherapy in metastatic colorectal cancer (MCRC) patients: Preliminary activity/toxicity report
    • Becouarn Y, Ychou M, Ducreux M, et al. Oxaliplatin (L-OHP) as first-line chemotherapy in metastatic colorectal cancer (MCRC) patients: preliminary activity/toxicity report. Proc Am Soc Clin Oncol 1997; 16: 229a.
    • (1997) Proc Am Soc Clin Oncol , vol.16
    • Becouarn, Y.1    Ychou, M.2    Ducreux, M.3
  • 7
    • 0012797224 scopus 로고    scopus 로고
    • Two consecutive phase two studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous fluoropyrimidines
    • Machover D, Diaz-Rubio E, de Gramont A, et al. Two consecutive phase two studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous fluoropyrimidines. Ann Oncol 1996; 7: 95-8.
    • (1996) Ann Oncol , vol.7 , pp. 95-98
    • Machover, D.1    Diaz-Rubio, E.2    De Gramont, A.3
  • 8
    • 0001385726 scopus 로고    scopus 로고
    • Oxaliplatin (L-OHP) and cisplatin (CDDP) in combination with 5-FU, specific thymidylate synthase (TS) inhibitors (AG337, ZD1694) and topoisomerase I (Topo-I) inhibitors (SN38, CPT-11), in human colonic, ovarian and breast cancers
    • Raymond E, Djelloul C, Buquet-Fagot F, et al. Oxaliplatin (L-OHP) and cisplatin (CDDP) in combination with 5-FU, specific thymidylate synthase (TS) inhibitors (AG337, ZD1694) and topoisomerase I (Topo-I) inhibitors (SN38, CPT-11), in human colonic, ovarian and breast cancers (meeting abstract). Proc Am Ass Cancer Res 1996; 291: 37.
    • (1996) Proc Am Ass Cancer Res , vol.291 , pp. 37
    • Raymond, E.1    Djelloul, C.2    Buquet-Fagot, F.3
  • 9
    • 0028036652 scopus 로고
    • Chronomodulated versus fixed-infusion-rate delivery ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: A randomized multi-institutional trial
    • Lévi F, Zidani R, Vannetzel JM, et al. Chronomodulated versus fixed-infusion-rate delivery ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J Natl Cancer Inst 1994; 86: 1608-17.
    • (1994) J Natl Cancer Inst , vol.86 , pp. 1608-1617
    • Lévi, F.1    Zidani, R.2    Vannetzel, J.M.3
  • 10
    • 0030888321 scopus 로고    scopus 로고
    • Oxaliplatin with high dose leucovorin and 5-fluorouracil 48-hour infusion in pretreated metastatic colorectal cancer
    • de Gramont A, Vignoud J, Tournigand C, et al. Oxaliplatin with high dose leucovorin and 5-fluorouracil 48-hour infusion in pretreated metastatic colorectal cancer. Eur J Cancer 1997; 33: 214-9.
    • (1997) Eur J Cancer , vol.33 , pp. 214-219
    • De Gramont, A.1    Vignoud, J.2    Tournigand, C.3
  • 11
    • 0025979845 scopus 로고
    • A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma
    • Ardalan B, Chua L, Hudes GR, et al. A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma. J Clin Oncol 1991; 9: 625-30.
    • (1991) J Clin Oncol , vol.9 , pp. 625-630
    • Ardalan, B.1    Chua, L.2    Hudes, G.R.3
  • 12
    • 0025338285 scopus 로고
    • Phase-I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate
    • Caussanel JP, Lévi F, Brienza S, et al. Phase-I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate. J Natl Cancer Inst 1990; 82: 1046-50.
    • (1990) J Natl Cancer Inst , vol.82 , pp. 1046-1050
    • Caussanel, J.P.1    Lévi, F.2    Brienza, S.3
  • 13
    • 0027461840 scopus 로고
    • Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer
    • Scheithauer W, Rosen H, Kornek GV, et al. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. Br Med J 1993; 306: 752-5.
    • (1993) Br Med J , vol.306 , pp. 752-755
    • Scheithauer, W.1    Rosen, H.2    Kornek, G.V.3
  • 14
    • 0026721532 scopus 로고
    • Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer evidence in terms of response rate
    • Advanced Colorectal Cancer Meta-analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer evidence in terms of response rate. J Clin Oncol 1992; 10: 896-903.
    • (1992) J Clin Oncol , vol.10 , pp. 896-903
  • 15
    • 0031019918 scopus 로고    scopus 로고
    • Randomised trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer
    • de Gramont A, Bosset JF, Milan C, et al. Randomised trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer. J Clin Oncol 1997; 15: 805-15.
    • (1997) J Clin Oncol , vol.15 , pp. 805-815
    • De Gramont, A.1    Bosset, J.F.2    Milan, C.3
  • 16
    • 0031015454 scopus 로고    scopus 로고
    • Fluorouracil in colorectal cancer: A tale of two drugs: Implications for biochemical modulation
    • Sobrero AF, Aschele C, Bertino JR. Fluorouracil in colorectal cancer: a tale of two drugs: implications for biochemical modulation. J Clin Oncol 1997; 15: 368-81.
    • (1997) J Clin Oncol , vol.15 , pp. 368-381
    • Sobrero, A.F.1    Aschele, C.2    Bertino, J.R.3
  • 17
    • 0028213430 scopus 로고
    • Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma
    • Weh HJ, Wilke J, Dierlamm J, et al. Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. Ann Oncol 1994; 5: 233-7.
    • (1994) Ann Oncol , vol.5 , pp. 233-237
    • Weh, H.J.1    Wilke, J.2    Dierlamm, J.3
  • 18
    • 0343255312 scopus 로고    scopus 로고
    • Irinotecan (CPT-11) multicenter phase II study in colorectal cancer patients with documented progressive disease on prior 5FU: Preliminary results
    • Vancutsem E, Cunningham D, Ten Bokkel Huinink W, et al. Irinotecan (CPT-11) multicenter phase II study in colorectal cancer patients with documented progressive disease on prior 5FU: preliminary results. Proc Am Soc Clin Oncol 1996; 15: 230.
    • (1996) Proc Am Soc Clin Oncol , vol.15 , pp. 230
    • Vancutsem, E.1    Cunningham, D.2    Ten Bokkel Huinink, W.3
  • 19
    • 0023708345 scopus 로고    scopus 로고
    • The definition of the 'No Change' category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast
    • Howell A, Mackintosh J, Jones M, Redford J, Wagstaff J, Sellwood RA. The definition of the 'No Change' category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast. Eur J Clin Oncol 1996; 24: 1557-72.
    • (1996) Eur J Clin Oncol , vol.24 , pp. 1557-1572
    • Howell, A.1    Mackintosh, J.2    Jones, M.3    Redford, J.4    Wagstaff, J.5    Sellwood, R.A.6
  • 20
    • 0028060451 scopus 로고
    • The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer
    • Graf W, Pahlman L, Bergstrom R, Glimelius B. The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer. Br J Cancer 1994; 70: 559-63.
    • (1994) Br J Cancer , vol.70 , pp. 559-563
    • Graf, W.1    Pahlman, L.2    Bergstrom, R.3    Glimelius, B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.